Orthodontic treatment for posterior crossbites
Orthodontic treatment for posterior crossbites
Cochrane Review
8 SoF Entries
Summary of Findings
Key results and quality assessments using GRADE methodology
| Outcome | Effect | Participants | Studies | Certainty |
|---|---|---|---|---|
|
Total Mortality
locoregional treatment |
0.92 | - | - | Not assessed |
|
Overall survival - platinum + 5-FU + RT vs. RT
locoregional treatment alone |
0.85 | - | - | Not assessed |
|
Overall survival - platinum + 5-FU + surgery vs. surgery
locoregional treatment alone |
1.06 | - | - | Not assessed |
|
Overall survival - cisplatin + 5-FU + docetaxel + CRT (cisplatin) vs. CRT (cisplatin)
locoregional treatment alone |
1.08 | - | - | Not assessed |
|
Overall survival - cisplatin + 5-FU + CRT (cisplatin) vs. CRT (cisplatin)
locoregional treatment alone |
0.71 | - | - | Not assessed |
|
Overall survival - adjuvant chemotherapy vs. observation alone
surgery +/- adjuvant treatment B |
0.95 | - | - | Not assessed |
|
Overall survival - adjuvant CRT vs. adjuvant RT
surgery +/- adjuvant treatment B |
0.84 | - | - | Not assessed |
|
Overall survival - CRT vs. RT
radiotherapy alone (non-resectable) |
0.74 | - | - | Not assessed |
GRADE Certainty of Evidence:
High
Very confident in the effect estimate
Moderate
Moderately confident in the effect estimate
Low
Limited confidence in the effect estimate
Very Low
Very little confidence in the effect estimate
Review Information
| Review ID: | CD006386 |
| Outcomes: | 8 assessed |
Related Content
Evidence Quality Distribution:
Not assessed:
8